Taiwan Advance Bio-Pharmaceutical Inc (ROCO:4186)
NT$ 19.1 0.55 (2.96%) Market Cap: 1.72 Bil Enterprise Value: 1.86 Bil PE Ratio: 0 PB Ratio: 7.35 GF Score: 60/100